Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF): 2019-2025

Historic Depreciation & Amortization (CF) for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $661,000.

  • IDEAYA Biosciences' Depreciation & Amortization (CF) rose 14.56% to $661,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 4.38%. This contributed to the annual value of $2.4 million for FY2024, which is 3.59% down from last year.
  • IDEAYA Biosciences' Depreciation & Amortization (CF) amounted to $661,000 in Q3 2025, which was down 7.94% from $718,000 recorded in Q2 2025.
  • IDEAYA Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $718,000 during Q2 2025, with a 5-year trough of $382,000 in Q1 2021.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $619,000 (2023), whereas its average is $622,000.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 31.75% in 2021, then declined by 9.84% in 2024.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Depreciation & Amortization (CF) stood at $448,000 in 2021, then rose by 24.55% to $558,000 in 2022, then climbed by 12.72% to $629,000 in 2023, then decreased by 9.06% to $572,000 in 2024, then increased by 14.56% to $661,000 in 2025.
  • Its last three reported values are $661,000 in Q3 2025, $718,000 for Q2 2025, and $600,000 during Q1 2025.